Distinction between pleural mesothelioma and pulmonary adenocarcinoma using MOC31 in an asbestos sprayer

Respiratory Medicine

Volumn 91, Issue 1, 1997, Pages 57-60

  Ryan, P J ^a,b   Oates, J L ^a   Crocker, J ^a   Stableforth, D E ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b HEREFORD COUNTY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG RESECTION; MALE; METASTASIS; PLEURA MESOTHELIOMA; PRIORITY JOURNAL;

EID: 0031043646     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(97)90137-2     Document Type: Article

References (10)

1. Selikoff IJ, Hammond EC, Churg J. Asbestos exposure, smoking and neoplasia. JAMA 1968; 204: 106-111.
2. Ameille J, Bernard N, Nores JM, Capron F, Remy JM. Pleural mesothelioma and renal adenocarcinoma simultaneously discovered in a patient exposed to asbestos. Rev Malad Resp 1993; 10: 42-43.
3. Fischbein A, Lou JC, Pinkston JR. Asbestosis, laryngeal carcinoma and malignant peritoneal mesothelioma in an insulation worker. Br J Indust Med 1991; 48: 338-341.
4. Dohner VA, Beegle RG, Miller WT. Asbestos exposure and multiple primary tumors. Am Rev Respir Dis 1975; 112: 181.
5. Kishimoto T, Okada K, Nagake Y et al. A case of asbestosis complicated with double cancer of the stomach and colon. Jap J Cancer Clin 1989; 35: 417-420.
6. Cagle PT, Wessels R, Greenberg SD. Concurrent mesothelioma and adenocarcinoma of the lung in a patient with asbestosis. Mod Pathol 1993; 6: 438-441.
7. Wick MR, Loy T, Mills SE, Legier JF, Manivel JC. Malignant epithelioid mesothelioma versus peripheral pulmonary adenocarcinoma: a histochemical, ultrastructural and immunohistologic study of 103 cases. Human Pathol 1990; 21: 759-766.
8. Brown RW, Clark GM, Tandon AK, Allred DC. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma. Human Pathol 1993; 24, 347-354.
9. Ruitenbeek T, Gouw AS, Poppema S. Immunocytology of body cavity fluids. MOC-31, a monoclonal antibody discriminating between mesothelial and epithelial cells. Arch Pathol Lab Med 1994; 118: 265-269.
10. Edwards C, Oates J. OV632 and MOC31 in the diagnosis of mesothelioma and adenocarcinoma: an assessment of their use in formalin fixed and paraffin wax embedded material. J Clin Pathol 1995; 48: 626-630.